Immune Registry for Organ Transplantation From COVID Positive Donors.

NCT05595837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-08-19

No results posted yet for this study

Summary

The purpose of this study is to collect data generated by standard clinical practice to determine the short term and long term clinical outcomes of recipients of solid organ transplantation from COVID-19 infected donors and compare it to recipients with organ transplant from COVID-19 negative donors.

Conditions

Interventions

OTHER

Standard organ transplant

Standard organ transplant procedures and follow up care

Sponsors & Collaborators

  • Eurofins

    collaborator INDUSTRY
  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Ambreen Azhar, MD · Virginia Commonwealth University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-29
Primary Completion
2025-07-20
Completion
2025-07-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05595837 on ClinicalTrials.gov